Lavipharm SA (LPHr)

Currency in EUR
1.4680
-0.0320(-2.13%)
Closed·
LPHr is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.46801.5140
52 wk Range
0.75601.7380
Key Statistics
Bid/Ask
1.476 / 1.398
Prev. Close
1.5
Open
1.49
Day's Range
1.468-1.514
52 wk Range
0.756-1.738
Volume
113.08K
Average Volume (3m)
169.65K
1-Year Change
80.1227%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LPHr Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 28, 2026
EPS / Forecast
-- / --
Revenue / Forecast
14,65M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.03%
Dividend Yield
1.33%
Industry Median 1.27%
Annualised payout
0.02
Paid annually
5-Years Growth
-
Growth Streak

LPHr Income Statement

Compare LPHr to Peers and Sector

Metrics to compare
LPHr
Peers
Sector
Relationship
P/E Ratio
49.5x10.3x−0.4x
PEG Ratio
-0.010.00
Price/Book
4.5x1.7x2.6x
Price / LTM Sales
4.0x1.7x3.0x
Upside (Analyst Target)
-24.6%51.5%
Fair Value Upside
Unlock2.4%8.8%Unlock

Lavipharm S.A. engages in the research, development, manufacture, import, marketing, sale, and wholesale of pharmaceutical, cosmetics, and healthcare products to physicians and pharmacists in Greece and internationally. The company offers pharmaceutical products for cardiology, oncology-urology, central nervous system, chronic pain, and self- treatment. It also provides prescription medicines and over the counter (OTC) products, as well as LIFELAB CBD products. The company was founded in 1911 and is based in Paiania, Greece.

Employees
285
Market
Greece

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
276,27K0,16%414,40K
Other Institutional Investors
0,000,00%0,00
Public Companies & Retail Investors
170,50M99,84%255,75M
Total
170,78M100,00%256,17M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dimensional Fund Advisors LP0,13%220 168330
DFA Investment Dimensions Group Inc. - Emerging Markets Core Equity 2 Portfolio0,09%161 049242

FAQ

What Is the Lavipharm SA (LPHr) Stock Price Today?

The Lavipharm SA stock price today is 1,4680 EUR.

What Stock Exchange Does Lavipharm SA Trade On?

Lavipharm SA is listed and trades on the Athens Stock Exchange.

What Is the Stock Symbol for Lavipharm SA?

The stock symbol for Lavipharm SA is "LPHr."

Does Lavipharm SA Pay Dividends? What’s The Current Dividend Yield?

The Lavipharm SA dividend yield is 1.33%.

What Is the Lavipharm SA Market Cap?

As of today, Lavipharm SA market cap is 250,7000M EUR.

What Is Lavipharm SA's Earnings Per Share (TTM)?

The Lavipharm SA EPS (TTM) is 0,0299.

From a Technical Analysis Perspective, Is LPHr a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Lavipharm SA Stock Split?

Lavipharm SA has split 5 times.

How Many Employees Does Lavipharm SA Have?

Lavipharm SA has 285 employees.

What is the current trading status of Lavipharm SA (LPHr)?

As of Jul 13, 2026, Lavipharm SA (LPHr) is trading at a price of 1,4680 EUR, with a previous close of 1,5000 EUR. The stock has fluctuated within a day range of 1,4680 EUR to 1,5140 EUR, while its 52-week range spans from 0,7560 EUR to 1,7380 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.